A Trial to Evaluate the Safety and Immune Response of an Investigational Pneumococcal Vaccine in Adults 50 To 64 Years of Age

NCT07105722 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

127

Enrollment

INDUSTRY

Sponsor class

Conditions

Pneumonia, Bacterial

Interventions

BIOLOGICAL: Pn-MAPS30plus
COMBINATION_PRODUCT: PCV20

Sponsor

GlaxoSmithKline